Literature DB >> 11676992

Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.

M Sanjak1, J Brinkmann, D S Belden, K Roelke, A Waclawik, H E Neville, S P Ringel, J R Murphy, B R Brooks.   

Abstract

Motor fatigue is a common complaint in patients with amyotrophic lateral sclerosis (ALS), but is often excluded, unlike weakness, from the clinical assessment of these patients. This could be due to the complexity and often painful assessment techniques of this motor deficit. This study examines the feasibility of quantitative assessment of motor fatigue by modifying presently available force measurements. The relationship between weakness and fatigue in ALS patients was also examined. Fifty-four ALS patients and 39 normal control subjects performed 30 s of sustained maximal voluntary isometric contraction (MVIC) of elbow flexors (EF), knee extensors (NE), and ankle dorsiflexors (DF), using a computerized force measurement system and standardized testing procedures. Fatigue index (FI) was digitally calculated, from the force-time curve, as the percentage of MVIC unable to be sustained over the 30-s period. Fatigue was greater in ALS patients than in normal control (mean=23% vs. 15%) in all muscles including muscles that were not clearly weak. Weakness and fatigue were poorly correlated in ALS patients and may be independent measures of the pathogeneses of ALS.

Entities:  

Mesh:

Year:  2001        PMID: 11676992     DOI: 10.1016/s0022-510x(01)00624-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

2.  Measures of functional performance and their association with hip and thigh strength.

Authors:  Roger Kollock; Bonnie L Van Lunen; Stacie I Ringleb; James A Oñate
Journal:  J Athl Train       Date:  2014-10-27       Impact factor: 2.860

3.  Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis.

Authors:  Steve Vucic; Arun V Krishnan; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

Review 4.  Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Kevin H J Park
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 5.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

6.  Dissecting the mechanisms underlying short-interval intracortical inhibition using exercise.

Authors:  Steve Vucic; Benjamin C Cheah; Matthew C Kiernan
Journal:  Cereb Cortex       Date:  2010-11-11       Impact factor: 5.357

Review 7.  Impairment Mechanisms and Intervention Approaches for Aged Human Neuromuscular Junctions.

Authors:  Yomna Badawi; Hiroshi Nishimune
Journal:  Front Mol Neurosci       Date:  2020-11-16       Impact factor: 5.639

8.  Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS.

Authors:  Jeffrey Rosenfeld; Ruth M King; Carlayne E Jackson; Richard S Bedlack; Richard J Barohn; Arthur Dick; Lawrence H Phillips; John Chapin; Deborah F Gelinas; Jau-Shin Lou
Journal:  Amyotroph Lateral Scler       Date:  2008-10

9.  Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model.

Authors:  Kevin H J Park; Sonia Franciosi; Blair R Leavitt
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.

Authors:  Abhirami K Iyer; Kathryn J Jones; Virginia M Sanders; Chandler L Walker
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.